By utilizing TZDs that function as high-affinity agonists of PPARγ [20], we demonstrate that TZD-induced activation of this nuclear receptor exerts anti-proliferative effects via promoting adipogenic differentiation in osteosarcoma cells. The gene discussed is PPARG; the disease is osteosarcoma.